How courts view experimental treatments.
The consequences of lawsuits brought by patients to obtain insurance coverage for autologous bone marrow treatment for breast cancer illustrate the problems that arise when health plans seek to exclude "experimental" treatments.
Anderson Kill Olick & Oshinsky, P.C., NY.
K L
KL
Gallinari
D016026:Bone Marrow Transplantation / Q000191:economics* / Q000592:standards; D001943:Breast Neoplasms / Q000191:economics / Q000601:surgery*; D017024:Chemotherapy, Adjuvant / Q000592:standards; D005260:Female; D006801:Humans; D007345:Insurance Claim Review / Q000331:legislation & jurisprudence*; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence; D016365:Liability, Legal / Q000191:economics*; D010415:Pensions; D012179:Retirement / Q000331:legislation & jurisprudence; D013219:State Government; D014481:United States